Prevalence, Costs, and Consequences of Low-Value Preprocedural Urinalyses in the US

JAMA Intern Med. 2021 Nov 1;181(11):1533-1535. doi: 10.1001/jamainternmed.2021.4075.

Abstract

This cohort study analyzes inpatient and outpatient episodes of procedural and surgical care to assess the prevalence and costs of low-value preprocedural urinalyses in the US from 2007 to 2017.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents* / economics
  • Anti-Bacterial Agents* / therapeutic use
  • Communicable Diseases / diagnosis
  • Communicable Diseases / epidemiology
  • Drug Resistance, Microbial / drug effects
  • Female
  • Guideline Adherence / statistics & numerical data
  • Humans
  • Low-Value Care*
  • Male
  • Medical Overuse* / economics
  • Medical Overuse* / prevention & control
  • Practice Guidelines as Topic
  • Preoperative Care* / methods
  • Preoperative Care* / standards
  • Preoperative Care* / statistics & numerical data
  • Prevalence
  • Procedures and Techniques Utilization* / economics
  • Procedures and Techniques Utilization* / statistics & numerical data
  • United States / epidemiology
  • Urinalysis* / economics
  • Urinalysis* / methods
  • Urinalysis* / statistics & numerical data
  • Urologic Diseases* / epidemiology
  • Urologic Diseases* / therapy
  • Urologic Diseases* / urine

Substances

  • Anti-Bacterial Agents